노벨상 수상 이후, 유도만능줄기세포(iPS cell)의 임상적 응용 | Bio리포트 > 동향

cell, iPS cell)가 세상에 등장하게 되었다. 이후 많은 연구자들에 의해 유도만능줄기세포를 생산하는 기술뿐만 아니라(Dr. Yamanaka에 의해 발견된 c-Myc, Klf4, Oct4, Sox2 뿐 아니라 Nanog [5], Lin28 [5]...

Could iPSCs Enable “Off-the-Shelf” Cell Therapy?: Cell

An “off-the-shelf” cell therapy derived from induced pluripotent stem cells (iPSCs) has entered clinical trials in the United States. Other companies are following suit, harnessing iPSCs’ self-rene...

Gene/ cell therapy 개발 현황 및 동향 | Bio리포트 > 동향

목 차 1. 서론 2. 본론 2.1. 유전자 치료 2.1.1. ex vivo 치료제와 in vivo 치료제 2.1.2. 바이러스벡터의 문제점 및 하이브리드벡터 개발 2.1.3. 지놈편집을 이용한 유전자 치료 2.1.4. 암 관련 유전자 치료 2.1.5....

Shinobi Therapeutics

IPS Cell therapies that · evade the immune · system

Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Pu - 팜뉴스

PALO ALTO, Calif., Nov. 2, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies...

Induced pluripotent stem cells | UCLA BSCRC

iPS cells are cells taken from a patient that are reprogrammed so that they can undergo differentiation The process by which stem cells transform into specific, specialized cell types with distinct...

Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcino....

Thangaraj et al. use human iPSC-derived NK cells that are engineered to inhibit TGF-β-mediated activity or to express anti-tumor chimeric antigen receptors, or both strategies combined. These studi...

Progress of iPS cell-based transplantation therapy for retinal diseases

The current progress in iPS cell-based retinal cell transplantation research for retinal diseases is summarized, addressing some remaining challenges and future prospects. The discovery of induced...

Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufactur....

iPS cell manufacturing organization researchers to integrat...

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived

of cell quality and dose but will also enable the therapy to be available to a globally impactful number of patients if successful. We, and others, have therefore focused our efforts toward...